|
US5852046A
(en)
*
|
1993-08-03 |
1998-12-22 |
Hoechst Aktiengesellschaft |
Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
|
|
US7208517B1
(en)
|
1994-08-19 |
2007-04-24 |
Abbott Labortories |
Endothelin antagonists
|
|
US6162927A
(en)
|
1994-08-19 |
2000-12-19 |
Abbott Laboratories |
Endothelin antagonists
|
|
US5767144A
(en)
*
|
1994-08-19 |
1998-06-16 |
Abbott Laboratories |
Endothelin antagonists
|
|
NZ330818A
(en)
*
|
1996-02-13 |
2000-05-26 |
Abbott Lab |
Benzo-1, 3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
|
|
AU2763602A
(en)
*
|
1996-02-13 |
2002-05-16 |
Abbott Laboratories |
Endothelin antagonists
|
|
ES2182029T3
(es)
*
|
1996-02-13 |
2003-03-01 |
Abbott Lab |
Derivados de acido 4-(benzo-1,3-dioxolil) pirrolidin-3-carboxilico como antagonistas de endotelina.
|
|
AU781355B2
(en)
*
|
1996-02-13 |
2005-05-19 |
Abbott Laboratories |
Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
|
|
US5801250A
(en)
*
|
1996-12-13 |
1998-09-01 |
Abbott Laboratories |
Process for the stereoselective production of nitro-enamine compounds
|
|
US6030975A
(en)
*
|
1997-03-14 |
2000-02-29 |
Basf Aktiengesellschaft |
Carboxylic acid derivatives, their preparation and use in treating cancer
|
|
HUP0002681A3
(en)
*
|
1997-06-17 |
2001-09-28 |
Abbott Lab |
Pyrrolidine carboxylic acid derivatives as endothelin antagonists and pharmaceutical compositions containing the same
|
|
TR200101234T2
(tr)
*
|
1997-08-04 |
2002-06-21 |
Abbott Laboratories |
Endotelin antagonistleri.
|
|
US6339087B1
(en)
|
1997-08-18 |
2002-01-15 |
Syntex (U.S.A.) Llc |
Cyclic amine derivatives-CCR-3 receptor antagonists
|
|
IL125658A0
(en)
|
1997-08-18 |
1999-04-11 |
Hoffmann La Roche |
Ccr-3 receptor antagonists
|
|
DE19743681A1
(de)
*
|
1997-10-02 |
1999-04-08 |
Knoll Ag |
Methode zur Verhinderung der Transplantatabstoßung
|
|
US6410554B1
(en)
|
1998-03-23 |
2002-06-25 |
Merck & Co., Inc. |
Combination therapy for the treatment of benign prostatic hyperplasia
|
|
AU5478799A
(en)
|
1998-09-14 |
2000-04-03 |
Warner-Lambert Company |
Branched alkyl pyrrolidine-3-carboxylic acids
|
|
EP1131290B1
(en)
|
1998-11-20 |
2008-02-20 |
F. Hoffmann-La Roche Ag |
Piperidine ccr-3 receptor antagonists
|
|
WO2002017912A1
(en)
*
|
2000-08-31 |
2002-03-07 |
Abbott Laboratories |
Endothelin antagonists
|
|
US8168616B1
(en)
|
2000-11-17 |
2012-05-01 |
Novartis Ag |
Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
|
|
GB0327839D0
(en)
|
2003-12-01 |
2003-12-31 |
Novartis Ag |
Organic compounds
|
|
NZ586285A
(en)
|
2004-03-17 |
2011-12-22 |
Novartis Ag |
Use of aliskiren in monotherapy for treating diabetes and metabolic disorder (syndrome X)
|
|
CA2904447C
(en)
|
2007-08-22 |
2017-01-03 |
Abbvie Deutschland Gmbh & Co Kg |
Therapy for complications of diabetes
|
|
WO2011114103A1
(en)
|
2010-03-18 |
2011-09-22 |
Biolipox Ab |
Pyrimidinones for use as medicaments
|
|
JO2998B1
(ar)
|
2010-06-04 |
2016-09-05 |
Amgen Inc |
مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان
|
|
JP6093770B2
(ja)
|
2011-09-27 |
2017-03-08 |
アムジエン・インコーポレーテツド |
癌の治療のためのｍｄｍ２阻害剤としての複素環化合物
|
|
US11407721B2
(en)
|
2013-02-19 |
2022-08-09 |
Amgen Inc. |
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
|
|
AU2014223547B2
(en)
|
2013-02-28 |
2017-11-16 |
Amgen Inc. |
A benzoic acid derivative MDM2 inhibitor for the treatment of cancer
|
|
JP6377123B2
(ja)
|
2013-03-14 |
2018-08-22 |
アムジエン・インコーポレーテツド |
癌の治療のためのｍｄｍ２阻害剤としてのヘテロアリール酸モルホリノン化合物
|
|
JOP20200296A1
(ar)
|
2013-06-10 |
2017-06-16 |
Amgen Inc |
عمليات صنع وأشكال بلورية من mdm2 مثبط
|
|
US8962675B1
(en)
*
|
2013-09-12 |
2015-02-24 |
Abbvie Inc. |
Atrasentan mandelate salts
|
|
KR102091932B1
(ko)
|
2018-08-16 |
2020-03-20 |
장남순 |
안전하고 간편한 접첩구조를 갖는 접이식 트램펄린
|